Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management

Area of Science:

• Gastroenterology
• Pediatric Gastroenterology
• Internal Medicine

Background:

• Inflammatory bowel diseases (IBD) encompass Crohn's disease (CD), ulcerative colitis (UC), and IBD-unclassified (IBDU).
• IBDU represents a distinct subgroup of chronic colitis lacking specific CD or UC features, potentially reclassifiable over time.
• IBDU is the least common IBD subtype, disproportionately affecting the pediatric population.

Purpose of the Study:

• To review current evidence on the diagnosis and management of IBDU.
• To provide insights into diagnostic work-up strategies for IBDU.
• To summarize medical and surgical treatment options for pediatric IBDU, addressing the lack of specific guidelines.

Main Methods:

• Comprehensive literature review focusing on diagnostic criteria and therapeutic approaches for IBDU.
• Analysis of clinical, endoscopic, histological, and imaging data for IBDU diagnosis.
• Evaluation of treatment strategies, including medical and surgical interventions, for IBDU.

Main Results:

• IBDU diagnosis requires a thorough work-up including clinical assessment, endoscopy, histology, and small bowel imaging.
• Current therapeutic strategies for IBDU are adapted from CD and UC protocols.
• Emerging data indicate IBDU may have a milder disease course and respond well to mesalamine, suggesting a lower therapeutic burden.

Conclusions:

• IBDU diagnosis is complex and requires a multidisciplinary approach.
• Pediatric IBDU management lacks established guidelines, necessitating evidence-based reviews.
• IBDU appears to be a distinct entity with a potentially favorable prognosis and specific treatment considerations.